1. Johansson SGO, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy, An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813–24.
2. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92: 44–7.
3. Queille C, Pommarede R, Saurat J-H. Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1984; 1: 246–53.
4. Walsh P, Aeling J, Huff L, Weston W. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids. J Am Acad Dermatol 1993; 29: 501–3.
5. Guidelines for treatment of atopic eczema. JEADV 2012; 26: 1045–60.
6. Peserico A, Städtler G, Sebastian M et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled stady. Br J Dermatol 2008; 158: 801–7.
7. Chen SL, Yan J, Wang FS. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials. J Dermatolog Treat 2010; 21: 144–56.
8. International Consensus Conference on Atopic Dermatitis II. Современная стратегия терапии атопического дерматита: программа действий педиатра. Согласительный документ Ассоциации детских аллергологов и иммунологов России.
М., 2006.
9. Баранов А.А., Хаитов Р.М. Аллергология и иммунология. Клинические рекомендации для педиатров. М.: Союз педиатров России, 2008.
10. Akdis CA et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61 (8): 969–87.